Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luveris + FSH for Fertility Preservation in Non-Hormone Sensitive Cancer
NCT06227949Phase 3Not yet recruiting
- Start
- Feb 2024
- Primary completion
- Dec 2029
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of lutropin alfa in infertility (2 arms). Primary endpoint: Total number of mature (MII) oocytes available for cryopreservation. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
lutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06227949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06227949.